Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.83 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.83 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.83 |
| ▸ | BLM | P54132 | 1/20 | 0.83 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.58 |
| ▸ | GSR | P00390 | 2/20 | 0.58 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.58 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.58 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.58 |
| ▸ | GRM8 | O00222 | 1/20 | 0.58 |
| ▸ | GRM6 | O15303 | 1/20 | 0.58 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.58 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.58 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.58 |
| ▸ | GRM5 | P41594 | 1/20 | 0.58 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.58 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.58 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.58 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.58 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glutamine SCHEMBL6555864 | 1.00 | KMT2A (0.83) | KMT2APMP22ALOX15BLMCYP1A2 | |
| Glutamine SCHEMBL3688684 | 1.00 | KMT2A (0.83) | KMT2APMP22ALOX15BLMCYP1A2 | |
| Glutamine SCHEMBL5848376 | 1.00 | KMT2A (0.83) | KMT2APMP22ALOX15BLMCYP1A2 | |
| Glutamine SCHEMBL104313 | 1.00 | KMT2A (0.83) | KMT2APMP22ALOX15BLMCYP1A2 | |
| Glutamine SCHEMBL3059857 | 1.00 | KMT2A (0.83) | KMT2APMP22ALOX15BLMCYP1A2 | |
| Glutamine SCHEMBL14485584 | 1.00 | KMT2A (0.83) | KMT2APMP22ALOX15BLMCYP1A2 | |
| Glutamine SCHEMBL4613452 | 1.00 | KMT2A (0.83) | KMT2APMP22ALOX15BLMCYP1A2 | |
| Glutamine SCHEMBL5085797 | 1.00 | KMT2A (0.83) | KMT2APMP22ALOX15BLMCYP1A2 | |
| Glutamine SCHEMBL20553625 | 1.00 | KMT2A (0.83) | KMT2APMP22ALOX15BLMCYP1A2 | |
| Glutamine SCHEMBL11170132 | 1.00 | KMT2A (0.83) | KMT2APMP22ALOX15BLMCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119265134-A | System, method and organoid suitable for organ/organoid circulatory culture | 苏州先觉生物科技有限公司 | 2025-01-07 | — | — | CN | claimed |
| US-10557854-B2 | CA IX—NIR dyes and their uses | On Target Laboratories, LLC (US) | 2020-02-11 | — | — | US | claimed |
| EP-0906333-B1 | SUBSTRATES AND INHIBITORS OF PROTEOLYTIC ENZYMES | MEDIVIR UK LTD (GB) | 2001-07-25 | — | — | EP | claimed |
| CN-119265134-A | System, method and organoid suitable for organ/organoid circulatory culture | 苏州先觉生物科技有限公司 | 2025-01-07 | — | — | CN | disclosed |
| US-20240261363-A1 | METHODS OF TREATING AND PREVENTING CANCER TREATMENT SIDE EFFECTS | FILAMENT BIOSOLUTIONS INC. | 2024-08-08 | — | — | US | disclosed |
| US-11987633-B2 | Cross-species-specific single domain bispecific single chain antibody | AMGEN RESEARCH (MUNICH) GMBH (DE) | 2024-05-21 | — | — | US | disclosed |
| CN-117357626-A | Peritoneal dialysis fluid | 杰拓保护有限公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-114345825-B | Mask cleaning method, cleaning liquid, cleaning apparatus, and method for manufacturing organic device | 大日本印刷株式会社 | 2023-08-22 | — | — | CN | disclosed |
| US-20230250406-A1 | MUTANT LIPASE AND USE THEREOF | DSM IP ASSETS B.V. (NL) | 2023-08-10 | — | — | US | disclosed |
| EP-3538065-B1 | COSMETIC FORMULATIONS FOR TOPICAL APPLICATIONS CONTAINING ERYTHROPOIETIN-DERIVED MOLECULES | ASC REGENITY LTD (GB) | 2023-08-02 | — | — | EP | disclosed |
| EP-4180458-A1 | CROSS-SPECIES-SPECIFIC PSMA X CD3 BISPECIFIC SINGLE CHAIN ANTIBODY | Amgen Research (Munich) GmbH (DE) | 2023-05-17 | — | — | EP | disclosed |
| EP-2038417-A2 | COMPOSITIONS AND METHODS FOR ENHANCING THE EFFICACY OF IL-2 MEDIATED IMMUNE RESPONSES | Merck Patent GmbH (DE) | 2009-03-25 | — | — | EP | disclosed |
| WO-2008119566-A2 | CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS | MICROMET AG (DE) | 2008-10-09 | — | — | WO | disclosed |
| WO-2008119565-A2 | CROSS-SPECIES-SPECIFIC BINDING DOMAIN | MICROMET AG (DE) | 2008-10-09 | — | — | WO | disclosed |
| WO-2008119567-A2 | CROSS-SPECIES-SPECIFIC CD3-EPSILON BINDING DOMAIN | MICROMET AG (DE) | 2008-10-09 | — | — | WO | disclosed |
| US-20080025947-A1 | Methods for enhancing the efficacy of IL-2 mediated immune responses | MERCK PATENT GMBH (DE) | 2008-01-31 | — | — | US | disclosed |
| WO-2008003473-A2 | COMPOSITIONS AND METHODS FOR ENHANCING THE EFFICACY OF IL-2 MEDIATED IMMUNE RESPONSES | MERCK PATENT GMBH (DE) | 2008-01-10 | — | — | WO | disclosed |
| EP-1437966-A4 | MEASUREMENT OF PROTEIN SYNTHESIS RATES IN HUMANS AND EXPERIMENTAL SYSTEMS BY USE OF ISOTOPICALLY LABELED WATER | UNIV CALIFORNIA (US) | 2006-08-23 | — | — | EP | disclosed |
| EP-1437966-A1 | MEASUREMENT OF PROTEIN SYNTHESIS RATES IN HUMANS AND EXPERIMENTAL SYSTEMS BY USE OF ISOTOPICALLY LABELED WATER | The Regents of the University of California (US) | 2004-07-21 | — | — | EP | disclosed |
| WO-2003061479-A1 | MEASUREMENT OF PROTEIN SYNTHESIS RATES IN HUMANS AND EXPERIMENTAL SYSTEMS BY USE OF ISOTOPICALLY LABELED WATER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10557854-B2 | CA IX—NIR dyes and their uses | CA9, CA13, CA4 | KMT2A 3624/4885PMP22 4778/4885ALOX15 1706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.